Protecting Democracy [1]

American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.

Tell Congress: Pass the Protecting Our Democracy Act

Add Your Name

Coalition Calls on Americans to Reject Trump’s Threat to the Rule of Law and U.S. Democracy

Working With The Not Above the Law Coalition to Call for January 6th Justice
Making Government Work [2]

The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.

Get Corporate Money Out of Politics

Sign the Petition

How Corporate Lobbyists Use the Executive Branch to Halt Progress

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors
Consumer & Worker Safeguards [3]

Every day, big banks, big polluters and big tech companies are threatening our economy, our environment and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.

Don’t Let Big Tech Write Our Digital Privacy Laws

Sign Now

Poll: 71% of Voters Support Strong Regulation to Protect the Public

Amazon’s Pandemic Price Gouging Shows Need for New Federal Law
Safe & Affordable Drugs & Devices [4]

Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.

Fight Pharma Greed

Take Action Now
Health Care [5]

Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.

Win Medicare for All

Take Action Now

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2017-2019

Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Globalization & Trade [6]

Our Mission

Global Trade Watch’s mission is to ensure that in this era of globalization, a majority have the opportunity to enjoy economic security, a healthy environment, safe food, medicines and products, access to quality affordable services such as health care and the exercise of democratic decision-making about the matters that affect our lives. Global Trade Watch has led the fight against corporate-rigged “trade” agreements that provide special powers for Big Pharma to raise medicine prices, promote the outsourcing of jobs to low-wage countries and undermine the food safety and other safeguards on which our families rely. For decades, we have fought for progressive alternatives that benefit people and the planet.

President Biden: No Secrecy in Indo-Pacific Trade Talks

Take Action

Indo-Pacific Economic Framework (IPEF)

Undemocratic WTO Processes Produce Shameful Result on Intellectual Property and Covid at 12th WTO Ministerial
Climate & Energy [7]

The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.

Tell Toyota: Go all-in on EVs

Add Your Name

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record
Justice & the Courts [8]

Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.

Subscribe to the Supreme Court Conference Preview

Sign Up

November 9, 2010

Testimony to IOM Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs

Sidney Wolfe, M.D.
Director of Health Research Group at Public Citizen

View as PDF.

Stay Updated on Public Citizen

Follow Public Citizen

Support Our Work

Donate

Menu

Tell Congress: Pass the Protecting Our Democracy Act

Coalition Calls on Americans to Reject Trump’s Threat to the Rule of Law and U.S. Democracy

Working With The Not Above the Law Coalition to Call for January 6th Justice

Get Corporate Money Out of Politics

How Corporate Lobbyists Use the Executive Branch to Halt Progress

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Don’t Let Big Tech Write Our Digital Privacy Laws

Poll: 71% of Voters Support Strong Regulation to Protect the Public

Amazon’s Pandemic Price Gouging Shows Need for New Federal Law

Fight Pharma Greed

Win Medicare for All

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2017-2019

Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit

Our Mission

President Biden: No Secrecy in Indo-Pacific Trade Talks

Indo-Pacific Economic Framework (IPEF)

Undemocratic WTO Processes Produce Shameful Result on Intellectual Property and Covid at 12th WTO Ministerial

Tell Toyota: Go all-in on EVs

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record

Subscribe to the Supreme Court Conference Preview

Share

Testimony to IOM Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs

Share

You might be interested in

Letter to OHRP on Unethical Trials of Indacaterol Maleate (Arcapta Neohaler)

Letter to HHS Regarding OHRP Failure to Investigate Unethical Placebo-Controlled Trials of Indacaterol Maleate (Arcapta Neohaler)

Trials of Prophylaxis to Prevent Recurrent Herpes Should Not Utilize a Placebo Arm

Comments on FDA Draft Guidance for Industry – Drug-Induced Liver Injury: Premarketing Clinical Evaluation

Stay Updated on Public Citizen

Follow Public Citizen

Support Our Work